| mRNA |
lapatinib |
CCLE |
pan-cancer |
AAC |
-0.23 |
3e-06 |
| mRNA |
Erlotinib |
CCLE |
pan-cancer |
AAC |
-0.21 |
3e-05 |
| mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
4e-05 |
| mRNA |
XL765 |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
0.0001 |
| mRNA |
VNLG/124 |
GDSC1000 |
pan-cancer |
AAC |
-0.13 |
0.0002 |
| mRNA |
epigallocatechin-3-monogallate |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.0003 |
| mRNA |
Doxorubicin |
gCSI |
pan-cancer |
AAC |
0.19 |
0.0004 |
| mRNA |
PF-184 |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0006 |
| mRNA |
SN-38 |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0007 |
| mRNA |
Tamoxifen |
GDSC1000 |
pan-cancer |
AAC |
0.12 |
0.0008 |